Jazz Pharmaceuticals (Nasdaq: JAZZ) will pay a premium of approximately
$1.5 billion to acquire Celator Pharmaceuticals Inc. (Nasdaq: CPXX). Shares of Jazz Pharmaceuticals slipped 53 cents to close at $151.56 while Celator Pharmaceuticals stock leaped $12.55 to close at $30.08.
Jazz Pharmaceuticals to buy Celator Pharmaceuticals
May 31, 2016 at 16:41 PM EDT